Wednesday, 4 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Results Update

Marksans Pharma Results Update

Marksans Pharma reported a record FY26 total income of ₹3,033.5 Crore, up 12.8% YoY. The company achieved historic highs in revenue, EBITDA, and PAT during the year.

Key figures
Value₹3,034 Cr
Source

BSE filing, NSE: MARKSANS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Marksans Pharma Ltd: key numbers

Share price
₹326.75
Market cap
₹14,807 Cr
Revenue (annual)
₹2,951 Cr
Net profit (annual)
₹417.9 Cr
P/E (TTM)
28.6×Sector 41.3×
Promoter holding
43.87%+0.00% QoQ
FII holding
19.06%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Marksans Pharma Ltd

All →

Other results update announcements

All →